Advertisement
Screener

Nektar Therapeutics (NKTR) Other

Nektar Therapeutics Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2025-03-14: Form 10-K; Item Well-known seasoned issuer; As filed No.
  • 2024-03-05: Form 10-K; Item Smaller reporting company; As filed No.
  • 2024-03-05: Form 10-K; Item Well-known seasoned issuer; As filed No.
  • 2023-11-08: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market.
FiledFormItemAs filed
2025-03-1410-KWell-known seasoned issuerNo
2024-03-0510-KSmaller reporting companyNo
2024-03-0510-KWell-known seasoned issuerNo
2023-11-0810-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2023-11-0810-QSmaller reporting companyNo
2023-08-0910-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2023-08-0910-QSmaller reporting companyNo
2023-05-1010-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2023-05-1010-QSmaller reporting companyNo
2023-02-2810-KStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2023-02-2810-KSmaller reporting companyNo
2023-02-2810-KWell-known seasoned issuerNo
2022-11-0410-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2022-11-0410-QSmaller reporting companyNo
2022-08-0510-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2022-08-0510-QSmaller reporting companyNo
2022-05-0610-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2022-05-0610-QSmaller reporting companyNo
2022-03-0110-KStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2022-03-0110-KSmaller reporting companyNo
2021-11-0510-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2021-11-0510-QSmaller reporting companyNo
2021-08-0610-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2021-08-0610-QSmaller reporting companyNo
2021-05-0710-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2021-05-0710-QSmaller reporting companyNo
2021-02-2610-KStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2021-02-2610-KSmaller reporting companyNo
2020-11-0610-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2020-11-0610-QSmaller reporting companyNo
2020-08-0710-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2020-08-0710-QSmaller reporting companyNo
2020-05-0810-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2020-05-0810-QSmaller reporting companyNo
2020-02-2810-KStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2020-02-2810-KSmaller reporting companyNo
2019-11-0710-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2019-11-0710-QSmaller reporting companyNo
2019-08-0910-QStock registered under Section 12(b)Common Stock, $0.0001 par value · NKTR · NASDAQ Global Select Market
2019-08-0910-QSmaller reporting companyNo
2019-05-0910-QSmaller reporting companyNo
2019-03-0110-KSmaller reporting companyNo
2018-11-0810-QSmaller reporting companyNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
UroGen Pharma Ltd. (URGN)$2.015B-18.42
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
Generate Biomedicines, Inc. (GENB)United States$2.052B
Biohaven Ltd. (BHVN)United States$1.990B-3.83
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Braveheart Bio, Inc. (BRVE)United States$2.106B
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89